logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

RVMD Skyrockets 285% in a Year on Historic Pancreatic Cancer Drug Breakthrough

RVMD Skyrockets 285% in a Year on Historic Pancreatic Cancer Drug Breakthrough

Jun 11, 2026

Life Science

Breaking Down VKTX: 188% Upside, Pipeline Progress and Key Risks

Breaking Down VKTX: 188% Upside, Pipeline Progress and Key Risks

Jun 10, 2026

Life Science

ESMO Readouts Steal the Spotlight, These Three Oncology Stocks Don't Need the Podium

GSK Pays 40% Premium to Buy Nuvalent in Major Oncology Push

Jun 9, 2026

Life Science

Up 100% Then Down 24%: Is the Moderna Pullback a Buying Opportunity?

Double Victory for Eli Lilly: Superior Weight-Loss Data & Bold Vaccine Expansion

Jun 8, 2026

Life Science

RVMD’s Near-100% Year-To-Date Rally Sparks Valuation Debate: Has the Stock Gotten Too Pricy?

RVMD’s Near-100% Year-To-Date Rally Sparks Valuation Debate: Has the Stock Gotten Too Pricy?

Jun 5, 2026

Life Science

Cameco Offers Stability, Uranium Energy Delivers Upside in the Uranium Upcycle

Two Beaten-Down Pharma Giants: Biotech’s Cyclical Turn Delivers Prime Dip-Buy Opportunities

Jun 4, 2026

Life Science

Moderna Outshines Pharma Giants Lilly, Merck and Pfizer With 43% Year-to-Date Surge

Moderna Outshines Pharma Giants Lilly, Merck and Pfizer With 43% Year-to-Date Surge

Jun 3, 2026

Life Science

ByteDance’s Anew Labs Emerges With $1.5B Valuation, Stirring New Questions Over AI Drug Discovery

Three AI Healthcare Stocks Chart Distinct Growth Trajectories

Jun 2, 2026

Life Science, Technology

Health Care Emerges as Defensive Haven as AI Trade Stumbles, Investors Rotate In

Healthcare ETF Face-off: VHT, IXJ and XBI – Which Fits Your Portfolio?

Jun 1, 2026

Life Science

5 Institutional-Approved High-Dividend Pharmaceutical Stocks for Passive Income Investors

5 Institutional-Approved High-Dividend Pharmaceutical Stocks for Passive Income Investors

May 29, 2026

Life Science

What Eli Lilly’s China Approval for Oral GLP-1 Weight-Loss Drug Means for Investors

Beyond Lilly and Novo Nordisk: Two Under-the-Radar Picks in the Obesity Drug Market

May 26, 2026

Life Science

Viking Therapeutics Aims High at $92 Target, But Clinical Risks Remain

Why Eli Lilly Is Underrated in the Red-Hot GLP-1 Weight-Loss Drug Race, per Morgan Stanley

May 25, 2026

Life Science

Pfizer’s 50% Stock Crash: A Hidden Contrarian Buy Amid Booming Healthcare Sector

Pfizer’s 50% Stock Crash: A Hidden Contrarian Buy Amid Booming Healthcare Sector

May 22, 2026

Life Science

“Rather Unfortunate”: White House Criticizes Fed’s Rate Hike, Trump Urges Quick Rate Cuts

Can Viking Therapeutics Replicate Eli Lilly’s Success in the Weight-Loss Drug Market?

May 21, 2026

Life Science

押注未来:瞄准2026年高增长潜力的两家生物科技公司

With the Macroeconomic Environment Improving, these Three Biotech Stocks Are Worth Watching

May 21, 2026

Life Science

生物技术IPO在未来几周将迎来增长,药物开发公司Maze Therapeutics预计是首家

Dyne Therapeutics Stock Rises 40% in a Year, but Saturn V Fund Reduces Holdings

May 20, 2026

Life Science

Teva's Remarkable Turnaround: From Pariah Stock to Wall Street Favorite

Teva’s Remarkable Turnaround: From Pariah Stock to Wall Street Favorite

May 15, 2026

Life Science

AI’s Visa Dependency Is a Hidden Market Risk

May 14, 2026

Life Science

  • ‹‹ Previous
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada